Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / chronic weight management (adults) | Covered with prior authorization |
Plan type: Commercial non-Medicare. Each indication below lists the BMI and clinical thresholds, the prior-authorization documentation, and the published policy it comes from.
This varies by plan. Blue Shield of California's clinical policy sets the criteria that apply when a plan covers weight-loss drugs, but coverage of that drug class is elected at the employer or group level. The policy states directly that 'the member's specific benefit may impact drug coverage,' and many commercial and self-funded groups exclude weight-loss agents. A member must confirm their own plan documents or formulary to know whether Zepbound for weight management is a covered benefit.
Coverage by indication
| BMI threshold | 30 or higher, or 27 or higher with a weight-related comorbidity |
What the prior authorization needs:
- Prior authorization with charted documentation
- BMI of 30 kg/m2 or higher, or BMI of 27 kg/m2 or higher with one weight-related condition (hypertension, diabetes, coronary artery disease, dyslipidemia, stroke, osteoarthritis, metabolic syndrome, prediabetes, PCOS, NASH, or sleep apnea currently treated with CPAP)
- Used as an adjunct to a reduced-calorie diet and increased physical activity
- Documented participation in a comprehensive lifestyle intervention (reduced-calorie diet, increased physical activity, behavioral modification) for at least 6 months within the past year
- Evaluated by a physician to rule out other underlying endocrine causes of obesity
- Not used in combination with another weight-loss agent or another GLP-1 agent
- No bariatric surgery within the previous 12 months
- Dose does not exceed the FDA label maximum
- Initial coverage period 4 months; first reauthorization requires at least 5% weight loss from baseline
Source: Weight Management Agents - Pharmacy Benefit Drug Policy. pharmacy_policy. Verified August 28, 2026.
Recent change: Per Blue Shield of California provider communications (April 2026), fully insured commercial HMO and PPO and select ASO members were moved from the single-dose Zepbound auto-injector to the multi-dose Zepbound KwikPen effective July 1, 2026. This is a delivery-form change: members need a new prescription for the KwikPen plus pen needles, but no new prior authorization for those with an existing approval.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- If the prior-authorization request is denied, the appeal letter library has templates by denial reason, covering peer-to-peer review, Level 1 and Level 2 internal appeal, and external review.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time. Some participants get a placebo, decided at random.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Blue Shield of California cover Zepbound?
Blue Shield of California runs a Weight Management Agents pharmacy policy that lists Zepbound as covered for chronic weight management in adults, but whether weight-loss drugs are a covered benefit at all depends on the member's employer group. Where the benefit is elected, Zepbound needs prior authorization: a BMI of 30 or higher, or 27 or higher with a weight-related condition such as hypertension, type 2 diabetes, dyslipidemia, or sleep apnea treated with CPAP, plus documented participation in a comprehensive lifestyle program (reduced-calorie diet, increased physical activity, behavioral modification) for at least 6 months in the past year. Reauthorization requires at least 5% weight loss from baseline. The policy does not list a separate obstructive sleep apnea indication for Zepbound; sleep apnea appears only as a qualifying comorbidity under the BMI 27 pathway. This reflects the published policy verified August 2026.
What does Blue Shield of California require to approve Zepbound?
For obesity / chronic weight management (adults): The BMI requirement is 30 or higher, or 27 or higher with a weight-related comorbidity.
Why might Blue Shield of California deny Zepbound even if I meet the criteria?
Blue Shield of California's clinical policy sets the criteria that apply when a plan covers weight-loss drugs, but coverage of that drug class is elected at the employer or group level. The policy states directly that 'the member's specific benefit may impact drug coverage,' and many commercial and self-funded groups exclude weight-loss agents. A member must confirm their own plan documents or formulary to know whether Zepbound for weight management is a covered benefit.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources; those rows are marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit. Those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
